Primary amyloidosis and myelomatosis associated with excessive fibrinolytic activity
- 1 May 1976
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 94 (5) , 569-571
- https://doi.org/10.1111/j.1365-2133.1976.tb05148.x
Abstract
A case of primary amyloidosis is described in association with Bence-Jones myeloma and increased fibrinolytic activity. .epsilon.-Aminocaproic acid reversed the fibrinolytic activity and clinical improvement was maintained with melphalan and prednisolone.This publication has 10 references indexed in Scilit:
- NEUROPATHY, M COMPONENTS, AND AMYLOIDThe Lancet, 1975
- A painful bleeding syndrome associated with increased fibrinolytic activityBritish Journal of Dermatology, 1974
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaThe American Journal of Medicine, 1973
- Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasiaArchives of Dermatology, 1973
- Immunoglobulins and amyloidosisThe American Journal of Medicine, 1972
- Plasminogen-activator-producing TumourBMJ, 1969
- FIBRINOLYSIS IN CITRATED AND OXALATED BLOODThe Lancet, 1967
- Amyloidosis with an Unusual Bleeding DiathesisAnnals of Internal Medicine, 1963
- Fibrinolysis and Changes in Fibrinogen in Multiple MyelomaArchives of internal medicine (1960), 1958
- Amyloid Disease of the HeartMedical Clinics of North America, 1950